TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
VRXA

Veraxa Biotech AG

Healthcare · Biotechnology

1.10$ -3.5% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Veraxa Biotech AG (VRXA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 2.7% of the shares are freely tradable; institutional investors hold 8.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 8.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 71.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 2.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 141Mio.

Largest Shareholders

Institutions

Institutions VRXA
Name Stake (%) Shares Change (%) Date
Picton Mahoney Asset Management 0.12 175,000 +0.0 06/30/2026
UBS Group AG 0.11 157,237 +0.0 06/30/2026
Geode Capital Management, LLC 0.08 119,767 +0.0 06/30/2026
HRT FINANCIAL LLC 0.01 18,874 +0.0 06/30/2026
Susquehanna International Group, LLP 0.01 10,833 +0.0 06/30/2026
Wolverine Asset Management LLC 0.00 1,748 +0.0 06/30/2026
JPMorgan Chase & Co 0.00 396 +0.0 06/30/2026

Funds

Funds VRXA
Name Stake (%) Shares Change (%) Date
Fidelity Nasdaq Composite Index 0.04 57,820 -32.8 08/31/2026
Fidelity Nasdaq Composite ETF 0.02 33,992 +0.0 10/30/2026
JNL Multi-Manager Alternative A 0.01 7,745 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings VRXA
Person Role Shares Value As of Type
Baumann Oliver Rolf Director 5,773,618 6,350,980 $ Aug 27, 2026 indirect
Ziegler Christoph Samuel Director 37,932 41,725 $ Oct 20, 2026 direct
Gruninger Marc Director 10,000 11,000 $ Oct 28, 2026 direct
Antz Christoph Rudiger Chief Executive Officer 5,000 5,500 $ Aug 27, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 28, 2026 Gruninger Marc Director Buy 9,133 1.00 9,133
Oct 27, 2026 Gruninger Marc Director Buy 867 0.98 850
Oct 20, 2026 Ziegler Christoph Samuel Director Buy 30,000 1.09 32,700
Aug 27, 2026 Baumann Oliver Rolf Director Buy 50,000 1.50 75,000
Aug 27, 2026 Antz Christoph Rudiger Chief Executive Officer Buy 5,000 1.53 7,650

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?